Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Punjab cohort of the A1chieve study.

Singh P, Singh KP, Priya G, Kapoor R.

Indian J Endocrinol Metab. 2013 Nov;17(Suppl 2):S534-7. doi: 10.4103/2230-8210.122120.

2.

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the East India cohort of the A1chieve study.

Sahoo AK, Das S, Prusty P, Shankar A, Guha S.

Indian J Endocrinol Metab. 2013 Nov;17(Suppl 2):S501-5. doi: 10.4103/2230-8210.122096.

3.
4.

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the West India cohort of the A1chieve study.

Jain SM, Jindal S, Malve H, Shetty R, Bhoraskar A.

Indian J Endocrinol Metab. 2013 Nov;17(Suppl 2):S486-90. doi: 10.4103/2230-8210.122091.

5.

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Kolkata cohort of the A1chieve study.

Majumder A, Singh AK, Gangopadhyay KK, Sen R, Shetty R, Majumdar S.

Indian J Endocrinol Metab. 2013 Nov;17(Suppl 2):S584-7. doi: 10.4103/2230-8210.122144.

6.
7.

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Karnataka cohort of the A1chieve study.

Deshpande N, Ayyar V, Channabasavaiah R, Shetty R, Behl A.

Indian J Endocrinol Metab. 2013 Nov;17(Suppl 2):S552-6. doi: 10.4103/2230-8210.122132.

8.
9.

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Haryana cohort of the A1chieve study.

Kalra S, Garg L, Suri S, Aggarwal S.

Indian J Endocrinol Metab. 2013 Nov;17(Suppl 2):S538-41. doi: 10.4103/2230-8210.122122.

10.

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Delhi cohort of the A1chieve study.

Tripathi S, Gera N, Motta A, Gupta R.

Indian J Endocrinol Metab. 2013 Nov;17(Suppl 2):S530-3. doi: 10.4103/2230-8210.122118.

11.
12.
13.
14.

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the North India cohort of the A1chieve study.

Kumar S, Zargar AH, Singhal S, Shetty R, Ganie MA, Bajaj S.

Indian J Endocrinol Metab. 2013 Nov;17(Suppl 2):S491-5. doi: 10.4103/2230-8210.122093.

15.
16.
17.

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Andhra Pradesh cohort of the A1chieve study.

Abubaker M, Rao YS, Zargar SH, Shetty R, Shankar R.

Indian J Endocrinol Metab. 2013 Nov;17(Suppl 2):S542-6. doi: 10.4103/2230-8210.122129.

18.

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the West Bengal cohort of the A1chieve study.

Mukhopadhyay S, Sengupta N, Ghosh S.

Indian J Endocrinol Metab. 2013 Nov;17(Suppl 2):S579-83. doi: 10.4103/2230-8210.122142.

19.

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Tamil Nadu cohort of the A1chieve study.

Shunmugavelu M, Giri J, Akhtar S, Shetty R, Asirvatham AJ.

Indian J Endocrinol Metab. 2013 Nov;17(Suppl 2):S569-73. doi: 10.4103/2230-8210.122139.

20.

Supplemental Content

Support Center